Viewing Study NCT02591732


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2025-12-31 @ 1:47 AM
Study NCT ID: NCT02591732
Status: COMPLETED
Last Update Posted: 2016-05-18
First Post: 2015-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module